ArticleVaccines2022

A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland-First Results.

Hanna Czajka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.